Does Rallies show Form 4 insider transactions for GKOS?

Yes. Rallies tracks GKOS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GKOS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GKOS. It does not provide personalized investment advice.

GKOS (Glaukos Corporation) Stock Analysis - Insider Trades

Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of May 21, 2026, GKOS trades at $137.25 with a market cap of $8.35B and a P/E ratio of -44.00. GKOS moved -2.54% today. Year to date, GKOS is +27.83%; over the trailing twelve months it is +47.52%. Its 52-week range spans $73.16 to $163.71. Analyst consensus is strong buy with an average price target of $142.91. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GKOS stock inside the company?

Recent GKOS insider activity includes Kliman Gilbert H sold 5.00K, Kliman Gilbert H sold 5.00K, Gilliam Joseph E sold 19.57K, WEN LEANA sold 1.70K, and Thurman Alex R. sold 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GKOS Key Metrics

Key financial metrics for GKOS
Metric	Value
Price	$137.25
Market Cap	$8.35B
P/E Ratio	-44.00
EPS	$-3.28
Dividend Yield	0.00%
52-Week High	$163.71
52-Week Low	$73.16
Volume	22.73K
Avg Volume	0
Revenue (TTM)	$507.44M
Net Income	$-187.69M
Gross Margin	55.72%

Recent GKOS Insider Trades

Kliman Gilbert H sold 5.00K (~$703.80K) on May 14, 2026.
Kliman Gilbert H sold 5.00K (~$675.00K) on May 11, 2026.
Gilliam Joseph E sold 19.57K (~$2.81M) on May 1, 2026.
WEN LEANA sold 1.70K (~$243.69K) on May 1, 2026.
Thurman Alex R. sold 10.00K (~$1.40M) on Apr 30, 2026.

Latest GKOS News

Glaukos dips 3% as new 8-K investor deck sparks post-earnings profit-taking — May 4, 2026
Glaukos jumps on record Q1 sales, iDose TR strength, and raised 2026 outlook — Apr 30, 2026
Glaukos Raises 2026 Sales Guidance to $620–$635M After 41% Q1 Revenue Surge — Apr 30, 2026
Glaukos slides 3% as traders de-risk ahead of Q1 earnings after the close — Apr 29, 2026
Glaukos jumps as Citi upgrades to Buy and raises target to $162 — Apr 17, 2026

GKOS Analyst Consensus

12 analysts cover GKOS: 0 strong buy, 11 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $142.91.

Common questions about GKOS

Who is trading GKOS stock inside the company?: Recent GKOS insider activity includes Kliman Gilbert H sold 5.00K, Kliman Gilbert H sold 5.00K, Gilliam Joseph E sold 19.57K, WEN LEANA sold 1.70K, and Thurman Alex R. sold 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GKOS?: Yes. Rallies tracks GKOS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GKOS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GKOS. It does not provide personalized investment advice.